References
[1] Giuliano, K.K. (2001) Continuous Physiologic Monitoring and the Identification of Sepsis: What Is the Evidence Supporting Current Clinical Practice? AACN Advanced Critical Care, 17, 215-223.
[2]
http://dx.doi.org/10.1097/01256961-200604000-00017
[3] Giuliano, K.K. (2007) Physiological Monitoring for Critically Ill Patients: Testing a Predictive Model for the Early Detection of Sepsis. American Journal of Critical Care, 16, 122-130.
[4] Póvoa, P. (2008) Serum Markers in Community-Acquired Pneumonia and Ventilator-Associated Pneumonia. Current Opinion in Infectious Diseases, 21, 157-162.
[5]
http://dx.doi.org/10.1097/QCO.0b013e3282f47c32
[6] Póvoa, P., Coelho, L., Almeida, E., Fernandes, A., Mealha, R., Moreira, P. and Sabino, H. (2006) Early Identification of Intensive Care Unit-Acquired Infections with Daily Monitoring of C-Reactive Protein: A Prospective Observational Study. Critical Care, 10, R63.
[7]
http://dx.doi.org/10.1186/cc4892
[8] Becker, K.L., Snider, R. and Nylen, E.S. (2008) Procalcitonin Assay in Systemic Inflammation, Infection, and Sepsis: Clinical Utility and Limitations. Critical Care Medicine, 36, 941-952.
[9]
http://dx.doi.org/10.1097/CCM.0B013E318165BABB
[10] Schütte, K. and Malfertheiner, P. (2008) Markers for Predicting Severity and Progression of Acute Pancreatitis. Best Practice & Research Clinical Gastroenterology, 22, 75-90.
[11]
http://dx.doi.org/10.1016/j.bpg.2007.10.013
[12] Matsumoto, K. and Nakamura, T. (1991) Hepatocyte Growth Factor: Molecular Structure and Implications for a Central Role in Liver Regeneration. Journal of Gastroenterology and Hepatology, 6, 509-519.
[13]
http://dx.doi.org/10.1111/j.1440-1746.1991.tb00897.x
[14] Nayeri, F., Nilsson, I., Brudin, L., Fryden, A., Söderström, C. and Forsberg, P. (2002) High Serum Hepatocyte Growth Factor Levels in the Acute Stage of Community-Acquired Infectious Diseases. Scandinavian Journal of Infectious Diseases, 34, 127-130.
[15]
http://dx.doi.org/10.1080/00365540110077236
[16] Ohnishi, H., Mizuno, S. and Nakamura, T. (2008) Inhibition of Tubular Cell Proliferation by Neutralizing Endogenous HGF Leads to Renal Hypoxia and Bone Marrow-Derived Cell Engraftment in Acute Renal Failure. American journal of Physiology. Renal Physiology, 294, F326-F335.
[17] Mizuno, S., Matsumoto, K. and Nakamura, T. (2008) HGF as a Renotrophic and Anti-Fibrotic Regulator in Chronic Renal Disease. Frontiers in Bioscience, 13, 7072-7086.
[18]
http://dx.doi.org/10.2741/3211
[19] Nayeri, F., Strömberg, T., Larsson, M., Brudin, L., Söderström, C. and Forsberg, P. (2002) Hepatocyte Growth Factor may Accelerate Healing in Chronic Leg Ulcers: A Pilot Study. Journal of Dermatological Treatment, 13, 81-86.
[20]
http://dx.doi.org/10.1080/095466302317584449
[21] Nayeri, F., Nilsson, I., Skude, G., Brudin, L. and Söderström, C. (1998) Hepatocyte Growth Factor (HGF) in Patients with Pneumonia: A Comparison between Survivors and Non-Survivors. Scandinavian Journal of Infectious Diseases, 30, 405-409.
[22]
http://dx.doi.org/10.1080/00365549850160729
[23] Nayeri, F., Millinger, E., Nilsson, I., Zetterström, O., Brudin, L. and Forsberg, P. (2002) Exhaled Breath Condensate and Serum Levels of Hepatocyte Growth Factor in Pneumonia. Respiratory Medicine, 96, 115-119.
[24]
http://dx.doi.org/10.1053/rmed.2001.1225
[25] Nayeri, F., Brudin, L., Darelid, J., Nilsson, I., Fryden, A., Söderström, C. and Forsberg, P. (2002) Hepatocyte Growth Factor May Act as an Early Therapeutic Predictor in Pneumonia. Scandinavian Journal of Infectious Diseases, 34, 500-504.
[26]
http://dx.doi.org/10.1080/00365540110080890
[27] Abednazari, H., Xu, J., Millinger, E., Brudin, L., Forsberg, P. and Nayeri, F. (2006) Hepatocyte Growth Factor Is a Better Indicator of Therapeutic Response than C-Reactive Protein within the First Day of Treatment in Pneumonia. Chemotherapy, 52, 260-263.
[28]
http://dx.doi.org/10.1159/000094868
[29] Smith, D.L. and Fehling, P.C. (1996) Reliability of Infrared Tympanic Thermometry (ITT). Aviation, Space, and Environmental Medicine, 67, 272-274.
[30] Rutherford, A.E., Hynan, L.S., Borges, C.B., Forcione, D.J., Blackard, J.T., Lin, W., Gorman, A.R., Shaikh, O.S., Reuben, A., Harrison, E., Reddy, K.R., Le, W.M. and Chung, R.T. (2007) Serum Apoptosis Markers in Acute Liver Failure: A Pilot Study. Clinical Gastroenterology and Hepatology, 5, 1477-1483.
[31]
http://dx.doi.org/10.1016/j.cgh.2007.08.007
[32] Celestin, R., Brown, J., Kihiczak, G. and Schwartz, R.A. (2007) Erysipelas: A Common Potentially Dangerous Infection. Acta dermatovenerologica Alpina, Panonica, et Adriatica, 16, 123-127.
[33] Dowd, S.E., Sun, Y., Secor, P.R., Rhoads, D.D., Wolcott, B.M., James, G.A. and Wolcott, R.D. (2008) Survey of Bacterial Diversity in Chronic Wounds Using Pyrosequencing, DGGE, and Full Ribosome Shotgun Sequencing. BMC Microbiology, 8, 43.
[34]
http://dx.doi.org/10.1186/1471-2180-8-43
[35] Conia, P.B., Davidson, H.L. and Lipsky, B.A. (2008) The Evaluation and Treatment of Complicated Skin and Skin Structure Infections. Expert Opinion on Pharmacotherapy, 9, 717-730.
[36]
http://dx.doi.org/10.1517/14656566.9.5.717
[37] Mandell, G.L., Bennett, J.E. and Dolin, R. (2009) Principles and Practice of Infectious Diseases. 15th Edition, Vol. 1, New York, Chruchill Livingstone, 604-607.
[38] Clyne, B. and Olshaker, J.S. (1999) The C-Reactive Protein. Journal of Emergency Medicine, 17, 1019-1925.
[39]
http://dx.doi.org/10.1016/S0736-4679(99)00135-3
[40] Meisner, M., Schmidt, J., Hüttner, H. and Tschaikowsky, K. (2000) The Natural Elimination Rate of Procalcitonin in Patients with Normal and Impaired Renal Function. Intensive Care Medicine, 26, S212-S216.
[41]
http://dx.doi.org/10.1007/s001340051146
[42] Hatzistilianou, M. (2010) Diagnostic and Prognostic Role of Procalcitonin in Infections. Scientific World Journal, 10, 1941-1946.
[43]
http://dx.doi.org/10.1100/tsw.2010.181
[44] Nayeri, F., Brudin, L., Nilsson, I. and Forsberg, P. (2002) Sample Handling and Stability of Hepatocyte Growth Factor in Blood Samples. Cytokine, 19, 201-205.
[45]
http://dx.doi.org/10.1006/cyto.2002.1050
[46] Liu, K., Kato, Y., Narukawa, M., Kim, D.C., Hanano, M., Higuchi, O., Nakamura, T. and Sugiyama, Y. (1992) Importance of Liver in Plasma Clearance of Hepatocyte Growth Factor in Rats. American Journal of Physiology, 263, G642-G649.